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FEVSerotonin is critical for shaping the development of neural circuits regulating emotion. Pet-1 (FEV-1) is an
ETS-domain transcription factor essential for differentiation and forebrain targeting of serotonin neurons.
Constitutive Pet-1 knockout (KO) causes major loss of serotonin neurons and forebrain serotonin availability, and
behavioral abnormalities. We phenotyped Pet-1 KO mice for fear conditioning and extinction, and on a battery of
assays for anxiety- and depression-related behaviors. Morphology of Golgi-stained neurons in basolateral amygdala
(BLA) and prelimbic cortex was examined. Using human imaging genetics, a common variant (rs860573) in
the PET-1 (FEV) gene was tested for effects on threat-related amygdala reactivity and psychopathology in 88
Asian-ancestry subjects. Pet-1 KO mice exhibited increased acquisition and expression of fear, and elevated fear
recovery following extinction, relative to wild-type (WT). BLA dendrites of Pet-1 KOmice were significantly longer
than inWT.HumanPET-1 variation associatedwith differences in amygdala threat processing andpsychopathology.
This novel evidence for the role of Pet-1 in fear processing and dendritic organization of amygdala neurons and in
human amygdala threat processing extends a growing literature demonstrating the influence of genetic variation
in the serotonin system on emotional regulation via effects on structure and function of underlying corticolimbic
circuitry.
© 2013 Elsevier Inc. All rights reserved.Introduction
The serotonin (5-hydroxytryptamine) neurotransmitter system plays
a key role in regulating emotion, and genetic variations in the serotonin
system influence individual differences in emotion and risk for emotional
disorders (Holmes, 2008). Genetically-driven variation in regulators of
serotonin signaling (e.g., tryptophan hydroxylase-2, Tph2; the serotonin
transporter, 5-HTT) is associated with higher levels of anxiety-like
behavior (Zhang et al., 2004) and deficient fear extinction (Wellman
et al., 2007), as well as increased dendritic arborization in ventromedial
prefrontal cortex (vmPFC) and higher spine density in basolateral
amygdala (BLA) neurons (Nietzer et al., 2011; Wellman et al., 2007).
In humans, a polymorphism in the 5-HTT promoter region is associated; Pet-1, FEV, Pheochromocytoma
PL, prelimbic cortex; 5-HTT, the
mPFC, ventromedial prefrontal
0th St., Bloomington, IN 47405,
).
ghts reserved.with functional uncoupling of prefrontal cortex (PFC) and amygdala
and amygdala hyperactivity in response to threat (Hariri et al., 2002;
Pezawas et al., 2005). Individuals with this polymorphism exhibit
impaired fear extinction (Hartley et al., 2012) and are at increased risk
for depression after a history of stressful life events (Caspi et al., 2010).
Given serotonin's role in brain development (Gaspar et al., 2003),
these effects may be driven by malformation of corticolimbic circuits
mediating anxiety and fear (Ansorge et al., 2007; Esaki et al., 2005;
Holmes et al., 2003). In this context, a major candidate for serotonergic
influences on brain development is the ETS domain transcription factor
Pet-1 (Pheochromocytoma 12 ets) aka FEV (Deneris, 2011). Pet-1 plays
a critical role in differentiation and forebrain targeting of serotonin
neurons, and expression of regulatory serotonin receptors on these
neurons (Hendricks et al., 2003; Liu et al., 2010). Pet-1 knockout (KO)
dramatically reduces the number of serotonin-immunoreactive neurons
from embryonic development onwards, resulting in an ~80% reduction
of serotonin in forebrain target regions (Deneris, 2011; Hendricks
et al., 2003).
Increased anxiety-like behavior has been reported in mice with
either constitutive Pet-1 KO (Hendricks et al., 2003) or Pet-1 KO
restricted to adulthood (Kiyasova et al., 2011; Liu et al., 2010;
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Pet-1 KO had enhanced conditioned fear behavior (Kiyasova et al.,
2011). Serotonergic effects on fear extinction are of particular clinical
relevance because deficits in fear extinction characterize anxiety disor-
ders such as posttraumatic stress disorder (PTSD) (Milad et al., 2009).
Indeed, disruption of serotonin genes produces morphological abnor-
malities in brain regions mediating fear extinction, notably the BLA
(Herry et al., 2010) and vmPFC (Burgos-Robles et al., 2009; Graybeal
et al., 2011; Wilber et al., 2011). However, the critical question of how
lifelong loss of serotonin affects extinction of learned fear behavior
remains unanswered.
Given the key role for the serotonergic systems in regulating
emotional behavior, here we assessed the consequences of Pet-1
deletion for fear extinction as well as anxiety-like behaviors and
stress responses. Further, emotional disorders are highly comorbid
with alcohol abuse and the serotonin system modulates EtOH's
effects on behavior. For example, disruption of serotonin signaling,
via 5-HTT KO, leads to exaggerated sensitivity to acute intoxicating
effects of EtOH (Boyce-Rustay et al., 2006; Daws et al., 2006). Therefore,
we also examined responses on an EtOH test battery. In addition, in a
separate cohort of behaviorally naïve mice, we examined potential
neural mechanisms at the level of dendritic arborization in BLA and
vmPFC. We hypothesized that mice with genetic inactivation of Pet-1
would show alterations in emotional behavior and corticolimbic
dendritic morphology relative to wild-type mice. We then interrogated
the potential translational impact of our preclinical analyses by
conducting a human neuroimaging genetics study of the association
between a common PET-1 (aka FEV) single nucleotide polymorphism
(rs860573) and threat-related amygdala reactivity, a human intermedi-
ate neural phenotype that reliably varies as a function of polymor-
phisms in serotonergic genes (Hariri and Holmes, 2006). The use of
non-human animal models allows for explicit manipulation of Pet-1,
while the extension in humans interrogating genetic variation within
the PET-1 gene (FEV) allows for preliminary translational evidence for
the importance of PET-1 in the emergence of individual differences in
clinically relevant brain function and the related risk for psychopathol-
ogy (Hariri, 2010). Thus, we hypothesized that genetic variation within
the PET-1 gene (FEV) would associate with differences in amygdala
reactivity; and these differenceswould parallel differences in emotional




Pet-1 null mutant mice were generated as previously described
(Hendricks et al., 2003) and repeatedly backcrossed into the C57BL/6J
strain for 10 generations. Wild-type (WT), heterozygous (HET), and
KO mice were littermates generated from HET × HET matings (Lerch-
Haner et al., 2008; Millstein et al., 2006). Mice were bred and
maintained at The Jackson Laboratory (Bar Harbor, ME) and shipped
to NIH at 7–9 weeks of age, or bred and maintained at NIH. Testing
began when mice were ≥10 weeks old. Mice were group-housed
with same-sex littermates in a temperature and humidity controlled
vivarium under a 12 h light/dark cycle (lights on 0600 h). Approxi-
mately equal numbers of males and females of each genotype were
used, with n = 22–24 per genotype for behavioral phenotyping and
n = 10–11 mice per genotype for dendritic analyses. All experimental
procedureswere approvedby theNIAAAAnimal Care andUse Committee
and followed the NIH guidelines ‘Using Animals in Intramural Research.’
Behavioral phenotyping
Testing was conducted with the putatively more stressful tests
later in the sequence (order of testing: novel open field test, elevated
plus-maze, light/dark exploration test, Pavlovian fear conditioningand extinction, home cage activity, and forced swim test). Seven days
elapsed between tests, except for the intervals between Pavlovian fear
conditioning and home cage activity (14 days) and between home
cage activity and forced swim test (2 days). There was then an interval
of 4 weeks before commencing the EtOH test battery. See Fig. 1 for a
summary of the time line of behavioral testing procedures. Except for
home cage activity, mice were first acclimated to the test room for
1 h. The experimenter remained blind to genotype during testing.
Pavlovian fear conditioning and extinction. Fear conditioning and extinc-
tion was assessed as previously described (Whittle et al., 2010; Yang
et al., 2008). Mice were placed in a 27 × 27 × 11 cm chamber with
transparentwalls and ametal rodfloor. To provide a distinctive olfactory
environment, the chamber was cleaned between subjects with a 79%
EtOH/20% water/1% vanilla extract solution. After a 180 s acclimation
period, mice received 3 pairings (60–120 s interval after each pairing)
of a tone (30 s, 80 dB, white noise) and footshock (2 s, 0.6 mA
scrambled footshock), with the shock occurring during the last 2 s
of the tone. Presentation of stimuli was controlled by theMedAssociates
Freeze Monitor system (Med Associates Incorporated, Georgia, VT).
Twenty-four hours later, expression of fear to the tone and subsequent
within-session extinction was tested in a novel context (Plexiglas
cylinder with black/white-checkered walls and a solid floor, cleaned
with a 1% acetic acid/99% water solution) housed in a novel room.
Following a 180 s acclimation period, mice received 50 × 30-s
presentations of the tone alone (5 s no-stimulus interval). Twenty-four
hours later, extinction retrieval was probed with 3 tone presentations.
Freezing (no visible movement except that required for respiration) to
the tone was manually scored every 5 s and converted to a percentage
([number of freezing observations/total number of observations] × 100).
Freezing during extinction trials was averaged into 10 × 5-trial blocks for
analysis.
Anxiety-related behavior and stress responsivity. Anxiety-related behav-
iors were assessed using the novel open field, elevated plus maze, and
light/dark exploration tests. Mice were tested for behavioral responses
to stress using the forced swim test (Porsolt et al., 1978). Thirtyminutes
after the final forced swim trial, blood was collected for corticosterone
assays. See Supplemental materials for full details.
Home cage locomotor activity. Locomotor activity was assessed in mice
individually housed in a standard home cage under normal vivarium
conditions and left undisturbed for a 48 h acclimation period (Karlsson
et al., 2008). Activitywas thenmeasured during the light and dark phases
over 24 husing thephotocell-basedOptoM3activitymonitor (Columbus
Instruments, Columbus, OH).
Behavioral responses to EtOH. Emotional disorders are highly comorbid
with alcohol abuse and the serotonin system modulates EtOH's effects
on behavior. For example, disruption of serotonin signaling, via 5-HTT
KO, leads to exaggerated sensitivity to acute intoxicating effects of
EtOH (Boyce-Rustay et al., 2006; Daws et al., 2006). Therefore we
tested mice on measures of acute intoxication (ataxia, hypothermia,
sedation/hypnosis in that order, each separated by a week). See
Supplemental materials for full details.
Dendritic morphology
In a separate set of behaviorally naïvemice, dendriticmorphology of
neurons in BLA and PL was assessed using a modification of Glaser and
Van der Loos' (1981) Golgi stain as described previously (e.g., Mozhui
et al., 2010).
Neurons were reconstructed in 180 μm coronal sections. Analysis of
BLA neurons was restricted to 0.8–2.0 mm posterior to bregma, where
BLA is readily identified in Golgi-stained material. Pyramidal neurons













Fig. 1. Time line of behavioral testing in WT and Pet-1 KO mice. Testing was conducted with the putatively more stressful tests later in the sequence. Seven days elapsed between tests,
except for the intervals between Pavlovian fear conditioning and home cage activity (14 days) and between home cage activity and forced swim test (2 days). Therewas then an interval
of 4 weeks before commencing the EtOH test battery.
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dendritic spines.
Pyramidal neurons in layers II–III of the prelimbic region (PL) of
vmPFC were drawn, as this region plays a role in the expression of
learned fear during extinction (Burgos-Robles et al., 2009), and stimula-
tion of PL impairs extinction (Vidal-Gonzalez et al., 2006). PL and layers
II–III were identified based on position and cytoarchitecture as
previously described (e.g., Mozhui et al., 2010). Pyramidal neurons in
PL had≥2 basilar dendritic treeswith≥third-order branches, a distinct,
single apical dendritic tree extending towards the pial surface, and
dendritic spines.
Neurons selected for reconstruction did not have truncated branches
and were not obscured by neighboring neurons and glia, with dendrites
that were easily discriminable by focusing through the depth of the
tissue. In 4–6 sections evenly spaced through the rostral–caudal extent
of each region, all pyramidal neurons meeting these criteria were identi-
fied. Eight neurons permouse per region (4 from each hemisphere)were
randomly selected from all identified neurons and reconstructed (final
magnification, 600×). Morphology was quantified using a computer-
based neuron tracing system (Neurolucida, MBF Bioscience, Williston,
VT) with the experimenter blind to genotype. Total length and number
of dendrites were measured. Amount and location of dendritic material
were assessed using a Sholl analysis (Larkman, 1991) in which the
number of intersections of dendrites with 10-μm concentric spheres
centered on the soma was measured. For statistical and graphical
purposes, counts of intersections were summed over pairs of radii.
Statistics
The effects of genotype × trial-block on freezing during extinction,
genotype × trial on forced swim test immobility, genotype × time for
open field and home cage activity, and genotype × distance from
soma were all analyzed using analysis of variance (ANOVA) withTable 1
Demographic and psychopathology variables by rs860573 genotype.
GG (n = 60) A carriers (n = 29
Gender (female n) 34 16
Age 19.55 ± 1.35 19.66 ± 1.45
Disorder present (n)a 3 8
MASQ AA 20.66 ± 5.40 22.95 ± 6.99
MASQ AD 53.38 ± 11.27 52.97 ± 14.76
MASQ GDA 16.67 ± 5.60 19.68 ± 6.50
MASQ GDD 19.81 ± 7.78 23.13 ± 10.04
STAI 38.30 ± 8.52 41.45 ± 10.75
MASQ, Mood and Anxiety Symptom Questionnaire; AA, anxious arousal; AD, anhedonic depre
AG: generalized anxiety disorder (n = 2); alcohol dependence (n = 2); alcohol abuse (n = 1)
comorbid alcohol abuse (n = 1); borderline personality disorder and comorbid bipolar II, alco
a GG: marijuana abuse (n = 1); alcohol abuse (n = 2).repeatedmeasures for trial-block, trial, time point, and distance, respec-
tively. For all other behavioral analyses, the effect of genotype was
analyzed using one-way ANOVA, followed by Newman–Keuls post hoc
tests where appropriate. For dendritic analyses, the effect of genotype
was assessed using one-way ANOVA. For Sholl analyses, the effects of
genotype × distance from soma were assessed using ANOVA with
repeated measures. Statistical significance was set at p b .05.
Human PET-1 imaging genetics
Participants
Genetic andneuroimagingdatawere available from375 participants
who completed the Duke Neurogenetics Study (Nikolova and Hariri,
2012), an ongoing protocol assessing a range of behavioral, experiential,
and biological phenotypes among young adult volunteers. All partici-
pants provided written informed consent in accordance with Duke
University guidelines and were in good general health. For completing
the study, each participant received $120 remuneration. Study exclu-
sion criteria included: 1) medical diagnoses of cancer, stroke, diabetes
requiring insulin treatment, chronic kidney or liver disease, or lifetime
history of psychotic symptoms; 2) use of psychotropic, glucocorticoid,
or hypolipidemic medication; and/or 3) conditions affecting cerebral
blood flow and metabolism (e.g., hypertension).
The Duke Neurogenetics Study seeks to measure variability in
behavior and neurobiology across a broad spectrum recognizing
the dimensional nature of these phenotypes. Accordingly,we thoroughly
assess psychopathology following categorical nosology but do not
exclude for it (with the exception of schizophrenia spectrum disorders).
Diagnosis of current DSM-IV Axis I and select Axis II disorders (Antisocial
Personality Disorder and Borderline Personality Disorder) was assessed
with the electronic Mini International Neuropsychiatric Interview) Genotype effect Total sample (n = 89)
χ2 = 0.018, p = 0.89 50
t(87) = 0.34, p = 0.74 19.60 ± 1.39
Fisher's exact: p = 0.005 11
t(87) = 1.70, p = 0.09 21.37 ± 6.00
t(87) = 0.15, p = 0.88 53.00 ± 12.58
t(87) = 2.26, p b 0.03 17.64 ± 6.01
t(87) = 1.71, p = 0.09 20.80 ± 8.66
t(87) = 1.50, p = 0.14 39.24 ± 9.34
ssion; GDA, general distress-anxiety; GDD, general distress-depression.
; alcohol dependence and comorbidmarijuana abuse (n = 1); marijuana dependence and
hol abuse, and marijuana abuse (n = 1).
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DSM-IV (SCID; First et al., 1997). These disorders were not exclusionary
(with the exception of schizophrenia spectrum disorders), as the DNS
seeks to establish broad variability in multiple behavioral phenotypes
related to psychopathology.
The final full sample consisted of 334 participants with amygdala
reactivity data following quality control procedures. Specifically,
data from 41 participants were excluded from analyses for the following
reasons: incidental structural brain abnormalities (n = 2), significant
movement outliers in fMRI data (n = 9; see preprocessing description),
inadequate signal in regions of interest (n = 7; see preprocessing
description), technical difficulties during fMRI data collection or
artifacts in data (e.g., coil problems; n = 3), or poor behavioral
performance (i.e., less than 75% accuracy: n = 20).
We examined genotypes for rs860573, an A➔G synonymous single
nucleotide polymorphism (SNP) located in exon 3 of the PET-1 gene
(FEV; Chromosome 2: 219,554,053-219,558,623; NCBI B36 assembly).
This is the only FEV SNP available to us from our genome-wide assess-
ment and the only variant tested in our current study. Because the
minor allele frequency of our target locus (rs860573) is rare in many
ethnic populations, the current analyses were restricted to 90 partici-
pants of self-identified Asian ancestry where theminor allele frequency
(MAF) was 17.24% to permit adequate sample sizes across possible
genotype groups, and to protect against confounding effects due to
population stratification. Genotyping at this locus failed for one Asian
participant resulting in a final sample of 89 in the present study
(Table 1 presents demographic and diagnostic data).Genotyping
Genotyping was conducted by 23andMe. Genomic DNA from all
participants was isolated from buccal cells derived from Oragene DNA
self-collection kits (DNA Genotek, Inc., Kanata, Ontario, Canada)
customized for 23andMe. DNA extraction and genotyping were
performed by the National Genetics Institute (NGI), a CLIA-certified
clinical laboratory and subsidiary of Laboratory Corporation of
America. The IlluminaOmni Express chip and a customarray containing
an additional ~300,000 SNPs were used to provide genome-wide data
(Do et al., 2011; Eriksson et al., 2010; Tung et al., 2011). The other ethnic
groups that compose the DNS had either too low MAF or too small
sample size to be included in analyses (African American n = 32,
MAF = 15.63%; European American n = 166, MAF = 0.60%; Latino
n = 22, MAF = 2.27%; Other n = 23, MAF = 15.22%). Genotype
frequencies for rs860573 did not deviate from Hardy–Weinberg
Equilibrium in the Asian only sample (χ2 = 1.21, p = 0.27). Because
only one participant was a minor allele homozygote, participants
were grouped as minor A allele carriers.Fig. 2. Amygdala reactivity paradigm. Participants match faces or geometric shapes. Face m
counterbalanced across participants.Self-report measures
As part of a behavioral self-report battery, participants completed
the Mood and Anxiety Symptoms Questionnaire (MASQ), which
provides subscale measures specific for current depressive and anxiety
symptoms (i.e., anhedonic depression and anxious arousal) as well as
shared across depressive and anxiety symptoms (i.e., general distress
anxiety and general distress depression) (Watson et al., 1995). Partici-
pants also completed the trait version of State Trait Anxiety Inventory
(STAI-T), a widely used measure capturing both negative affect and
anxiety (Spielberger et al., 1983).
Amygdala reactivity paradigm
The experimental fMRI paradigm consists of 4 blocks of a face-
processing task interleaved with 5 blocks of a sensorimotor control
task (Brown et al., 2005; Hariri et al., 2009; see Fig. 2). Participant
performance (accuracy and reaction time) is monitored during all
scans using an MR-compatible button box. During task blocks, partici-
pants view a trio of faces and select one of two faces (bottom) identical
to a target face (top). In the DNS version of the task, there are four task
blocks with neutral, angry, fearful, or surprised facial expressions
derived from a standard set of pictures of facial affect (Ekman and
Friesen, 1976). The order of the expression-specific task blocks is
counter-balanced across participants. During the sensorimotor control
blocks, participants perform the same target-matching taskwith simple
geometric shapes (circles and ellipses). Each sensorimotor control block
consists of six different shape trios. All blocks are preceded by a brief
instruction (“Match faces” or “Match shapes”) that lasts 2 s. In the
task blocks, each of six face trios (three all male faces and three all
female faces) is presented for 4 s with a variable interstimulus interval
(ISI) of 2 to 6 s (mean, 4 s), for a total block length of 48 s. A variable
ISI is used to minimize expectancy effects and resulting habituation,
and maximize amygdala reactivity throughout the paradigm. In the
control blocks, each of the six shape trios is presented for 4 s with a
fixed interstimulus interval of 2 s, for a total block length of 36 s.
Total task length is 390 s. Bilateral threat-related basolateral and
centromedial amygdala reactivity to blocks containing angry and
fearful facial expressions were extracted using the general linear
model of SPM8 (p b .05, FWE corrected) across all participants.
BOLD fMRI data acquisition
Participantswere scanned using a research-dedicated GEMR750 3 T
scanner equippedwith high-power high-duty-cycle 50-mT/mgradients
at 200 T/m/s slew rate, and an eight-channel head coil for parallel
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Fig. 3. Increased acquisition and maintenance of fear in Pet-1 KOmice. Pet-1 KOmice and
WT controls did not differ at baseline (trial 0), but Pet-1 KOmice showed higher freezing
than WT controls on the second and third tone exposures during conditioning. Freezing
washigher in Pet-1KOmice thanWT controls during initial fear retrieval and all extinction
trial-blocks except the last two. During extinction retrieval, freezing was again higher in
Pet-1 KO mice than WT controls. n = 22–24 per genotype. Data are Means ± SEM.
*p b .05 vs. WT.
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was used to ensure global field homogeneity. A series of 34 interleaved
axial functional slices aligned with the anterior commissure–posterior
commissure (AC–PC) plane were acquired for full-brain coverage
using an inverse-spiral pulse sequence to reduce susceptibility
artifact (TR/TE/flip angle = 2000 ms/30 ms/60; FOV = 240 mm;
3.75 × 3.75 × 4 mm voxels; interslice skip = 0). Four initial RF
excitations were performed (and discarded) to achieve steady-state
equilibrium. To allow for spatial registration of each participant's data
to a standard coordinate system, high-resolution three-dimensional
structural images were acquired in 34 axial slices co-planar with the
functional scans (TR/TE/flip angle = 7.7 s/3.0 ms/12; voxel size =
0.9 × 0.9 × 4 mm; FOV = 240 mm, interslice skip = 0).
BOLD fMRI data analysis
The general linear model of SPM8 (http://www.fil.ion.ucl.ac.uk/
spm) was used for whole-brain image analysis. Individual subject data
were realigned to the first volume in the time series to correct
for head motion before being spatially normalized into the standard
stereotactic space of the Montreal Neurological Institute template
using a 12-parameter affine model. Data were then smoothed to
minimize noise and residual differences in individual anatomy with
a 6 mm FWHM Gaussian filter. Next, the ARtifact detection Tool
(ART) was used to generate regressors accounting for the possible
confounding effects of volumes with large motion deflections (i.e.,
N0.6 mm relative to the previous time frame) or spiking artifacts
(i.e., global mean intensity 2.5 standard deviations from the entire
time series). Nine participants, who had more than 5% of their acqui-
sition volumes flagged by ART, were dropped from analyses. Because
of the signal loss and noise often observed in amygdala and adjacent
regions, single-subject BOLD fMRI data were included in subsequent
analyses only if there was a minimum of 90% signal coverage in
amygdala [using a bilateral ROI created from the Automated
Anatomical Labeling (AAL) atlas (Tzourio-Mazoyer et al., 2002)
using the Wake Forest University PickAtlas toolbox in SPM8]. Seven
participants were excluded due to ≤90% coverage.
Following preprocessing, linear contrasts employing canonical
hemodynamic response functions were used to estimate task-specific
(i.e., Angry and Fearful Faces N Shapes) BOLD responses for each indi-
vidual. Individual contrast images (i.e., weighted sum of the beta
images) were then used in second-level random effect models account-
ing for scan-to-scan and participant-to-participant variability to deter-
mine mean task-specific regional responses using one-sample t-tests.
A voxel-level statistical threshold of p b .05, FWE corrected for multiple
comparisons across the amygdala regions of interest, and a cluster-level
extent threshold of 10 contiguous voxels was applied to this analysis.
Bilateral centromedial and basolateral amygdala regions of interest
(ROIs) were defined using anatomical probability maps (Amunts et al.,
2005). BOLD parameter estimates from clusters within right and left
centromedial and basolateral amygdala ROIs exhibiting main effects of
taskwere extracted using the VOI tool in SPM8 and exported for regres-
sion analyses in SPSS (v.18). Extracting parameter estimates from
maximal clusters activated by our fMRI paradigm, rather than clusters
specifically correlated with our independent variables of interest, is a
more conservative analytic strategy that precludes the possibility of
any correlation coefficient inflation thatmay resultwhen an explanatory
covariate is used to select a region of interest (Bogdan et al., 2012;
Nikolova and Hariri, 2012).
Statistical analyses
To evaluate genotype effects on amygdala reactivity, linear regression
analyses were conducted within SPSS (v18) to test the association
between rs860573 genotype (i.e., G homozygotes, A allele carriers) and
extracted threat-related amygdala reactivity (i.e., angry and fear N shapescontrast) using gender and the presence of a psychiatric disorder as
covariates. For analyses of disorder status, as well as depressive and
anxiety symptoms, independent samples t-tests or chi-square tests
were used. For post-hoc exploratory mediational analyses we used the
Process SPSS expansion (Hayes, 2013).
Results
Pet-1 KO show increased acquisition, expression and post-extinction
recovery of fear
There were significant effects of genotype (F2,67 = 3.31, p b .05)
and trial (F3,201 = 135.51, p b .01) and a borderline genotype × trial
interaction (F6,201 = 2.10, p = .0546) for freezing during condition-
ing. Post hoc tests showed that freezing was not different between
genotypes at baseline or during the first tone exposure prior to pairing
with the first shock, but was significantly higher in Pet-1 KO mice than
WT controls during the second and third tone exposures (Fig. 3).
There was a genotype × trial interaction for freezing during fear
retrieval and extinction testing (F20,670 = 3.18, p b .01). Post hoc
tests showed that freezing was significantly higher in Pet-1 KO
mice than WT controls on all extinction trial-blocks except the last
two (Fig. 3). Freezing was again higher in Pet-1 KO mice than WT
controls during extinction retrieval (main effect of genotype:
F2,67 = 4.86, p b .05, followed by post hoc tests) (Fig. 3).
Pet-1 KO show dendritic hypertrophy in BLA, but normal dendritic
arborization in PL
For BLAneurons, therewas a significant effect of genotype on average
dendritic length (F2,28 = 3.69, p b .05) (Fig. 4B), but not on number of
branches (Fig. 4C). Post hoc tests showed that Pet-1 KOmice had longer
dendritic arbors than WT controls. Sholl analysis of dendritic intersec-
tions found a significant effect of genotype (F2,28 = 4.28, p b .05) and
distance from soma (F10,140 = 459.52, p b .01), but no interaction
(Fig. 4D). Simple main effects analysis showed that Pet-1 KO mice had
more intersections than WT controls (F1,19 = 8.06, p b .05).
In PL, there was no effect of genotype on average apical or basilar
dendritic length or branch number (Figs. 5B–E). Sholl analysis found a
significant effect of distance from soma but not genotype (and no inter-
action) for apical (F7,196 = 187.80, p b .01) and basilar (F6,168 =
551.16, p b .01) intersections (Figs. 5F–G).
Fig. 4. Dendritic hypertrophy in BLA of Pet-1 KO mice. (A) Examples of BLA neuronal
reconstructions. (B) Average dendritic length of BLA neurons was greater in Pet-1
KO mice as compared to WT controls (n = 10–11 mice per genotype, n = 8 neurons
per mouse). (C) Genotypes did not differ in the number of BLA dendritic branches.
(D) Increases in dendritic material were distributed uniformly throughout the
dendritic arbor. Scale bar = 50 μm. Data are Means ± SEM. *p b .05 vs. KO.
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forced swim
Total distance traveled and percent center time in the novel open
field test did not vary with genotype (Supplementary Figs. S1A–B). All
genotypes showed habituation of locomotor activity in this test (main
effect of timebin: F5,335 = 37.29, p b .01, timebin × genotype interac-
tion: ns). In the elevated plus-maze, genotypes did not differ in percent
open arm time, open arm entries (WT = 8.64 ± 1.13, HET = 7.83 ±
0.61, KO = 8.50 ± 0.93) or closed arm entries (Supplementary
Figs. S1C–D). Genotypes also showed similar percent time in the
light compartment and light compartment entries during the first
(Supplementary Figs. S1E–F) and last (data not shown) 5 min of
the light/dark exploration test.
There was no effect of genotype on immobility in the forced swim
test (Supplementary Fig. S2A). There was a significant overall increase
in immobility from trial 1 to trial 2 (main effect of trial: F1,28 = 4.80,
p b .05; trial × genotype interaction: ns). Genotypes did not differ in
corticosterone responses to trial 2 (Supplementary Fig. S2B) and all
showed significantly higher corticosterone levels after swim, as
compared to non-swum controls (main effect of swim: F2,55 = 31.06,
p b .01, swim × genotype interaction: ns).
Pet-1 KO show normal home cage circadian activity, impaired rotarod
motor coordination
Home cage activity significantly changed over the circadian cycle,
but genotypes did not differ in the pattern or overall level of activity
(Supplementary Figs. S3A–B) (main effect of time of day: F95,1425 =
2.74, p b .01;main effect of genotype: ns; time of day × genotype inter-
action: ns) (for a fuller analysis of this behavior, see Paulus and Mintz,
2011).
In the accelerating rotarod, there was a significant effect of genotype
(F2,43 = 3.60, p b .05) and trial (F9,387 = 12.66, p b .01), but no
genotype × trial interaction, for latency to fall. Simple main effect
analysis revealed that Pet-1 KO mice had lower latencies than WT
controls (F1,27 = 4.82, p b .05) (Supplementary Fig. S3C).
Pet-1 KO show normal responses to acute EtOH challenge
There was no effect of genotype on delta latency to fall from the
accelerating rotarod following EtOH injection (Supplementary Fig. S4A).
EtOH produced a clear hypothermic response but this did not differ
between genotypes (Supplementary Fig. S4B). Sleep time responses
were also similar across genotypes (Supplementary Fig. S4C).
Human PET-1 gene variation predicts amygdala reactivity to threat
The imaging task robustly recruited bilateral basolateral and
centromedial amygdala reactivity (Fig. 6). Regression analyses revealed
significant effects of rs860573 genotype on left centromedial and right
basolateral threat-related amygdala reactivity (left centromedial:
standardized beta = 0.29; ΔF(1,84) = 6.72, ΔR2 = .073, p b .02;
right basolateral: standardized beta = 0.25; ΔF(1,84) = 5.08, ΔR2 =
.056, p b .03). Specifically, carriers of the minor A allele exhibited
significantly increased right basolateral and left centromedial amygdala
reactivity in comparison with major G allele homozygotes (Fig. 6).
Genotype did not predict left basolateral (standardized beta = 0.19;
ΔF(1,84) = 2.97,ΔR2 = .034, p N .08) or right centromedial (standard-
ized beta = 0.05; ΔF(1,84) = 0.90, ΔR2 = .01, p N .34) reactivity. A
allele carriers also had higher rates of psychopathology (Fisher's
exact: p b .005) and greater general distress anxiety as measured
by the MASQ (p b .03); however, while anxiety as measured by the
STAI was elevated in A allele carriers, the association did not reach
statistical significance (p = .13; Table 1). There was no evidencethat amygdala reactivity mediated self-reported differences in
anxiety or depressive symptomatology.
Discussion
The major findings of the current study were that 1) in mice, Pet-1
deletion produced amygdala dendritic hypertrophy and an augmented,
extinction-resistant fearmemory, and, 2) in humans, a PET-1 gene (FEV)
variant associated with threat-driven amygdala reactivity and risk for
psychopathology. Importantly, particularly in light of the importance
of replication even with intermediate biological phenotypes (but see
also Goldman and Ducci, 2007; Hart et al., 2013), our human imaging
genetics results should be viewed as preliminary. Our relatively small
sample also limits the inferential value of our observed association
with psychiatric disorder, which similarly requires replication ideally
in larger samples.
Increased, recovery-prone, fear in PET-1 KO mice
Pet-1KOmice showed rapid, one-trial augmentation of fearmemory
acquisition,with higher freezing thanWT controls as early as the second
exposure to a conditioned stimulus during fear conditioning and
increased fear the following day, which persisted during much of
extinction training. Nonetheless, over extinction training trials, KO fear
levels decreased to a level similar to WT. These patterns reflect
sustained expression of an increased fear response in KO rather than a
deficit in extinction learning. However, despite extinguishing to WT
266 C.L. Wellman et al. / Experimental Neurology 250 (2013) 260–269levels, KO showed significant fear recovery on an extinction-retrieval
test the following day. Thus, lifelong loss of serotonin not only
strengthens the formation and expression of fear, consistent with
previous work (Kiyasova et al., 2011), but also weakens the capacity
for fear extinction training to produce lasting reductions in fear. This
pattern is similar to that reported in anxiety and stress-related disorders,
such as PTSD, where symptoms are liable to reoccur in the presence of
trauma reminders, even after exposure therapy (Bradley et al., 2005;
Felmingham and Bryant, 2012; Milad et al., 2009).
These findings are also reminiscent of the phenotype in othermouse
models of constitutive serotonin loss (Fernandez andGaspar, 2012). For
instance, mutants with deletion of Lmx1b in the raphé nuclei exhibited
increased acquisition and expression of conditioned contextual fear,
although extinction was not tested (Dai et al., 2008). This convergence
of findings across mouse models supports strong penetrance of effects
of constitutive serotonin loss on fear behavior.Amygdala dendritic hypertrophy in PET-1 KO mice
Pet-1 KO mice had significant expansion of BLA dendritic arbors.
Although we did not detect abnormalities in PL dendritic morphology,
activity of PL neurons positively correlates with fear and poor extinction
in rats (Burgos-Robles et al., 2009; Wilber et al., 2011), and further
studies are needed before discounting the contribution of abnormal PL
function to Pet-1 KO fear behavior. Similar changes in BLA arborization
are found in an inbredmouse strain exhibiting resistance to fear extinc-
tion (Camp et al., 2012), and increased BLA dendritic spine density isFig. 5. Normal dendritic arborization in PL of Pet-1 KO mice. (A) Examples of PL neuronal reco
average number of apical (D) or basilar (E) dendritic branches, or apical (F) or basilar (G) d
bar = 50 μm. Data are Means ± SEM.found in extinction-impaired mutant mice lacking 5-HTT (Nietzer
et al., 2011; Wellman et al., 2007). Further, chronic stress causes BLA
dendritic hypertrophy in rats, which may contribute to stress-induced
changes in emotional behaviors (Roozendaal et al., 2009). Collectively,
these findings show that BLA dendritic hypertrophy is a reliable
correlate of excessive fear.
This is consistent with lesion studies demonstrating that the BLA
complex is critical for the formation and expression of the Pavlovian
fear memory (Anglada-Figueroa and Quirk, 2005; Ehrlich et al., 2009;
LeDoux, 2000). Expansion of BLA dendritic arbors in Pet-1 KO mice
could provide a neural substrate for enhanced encoding of fear
memories, possibly by increasing the availability of synapses at
which plasticity can occur. Given that serotonin is generally considered
to be a trophic factor, dendritic hypertrophy in Pet-1 KO mice might
seem paradoxical. However, consistent with our findings, a recent
study demonstrated decreased dendritic length in BLA of MAO-A
knockout mice (Bortolato et al., 2011). Serotonin axons innervate
pyramidal neurons and inhibitory interneurons in the BLA (Muller
et al., 2007), and multiple serotonin receptor subunits are expressed
on both cell types. Therefore, the net effect of either excess or diminished
serotonin in this region is likely to be highly complex. Parsing the
mechanisms involved awaits future study.Phenotypic specificity and genetic background modification
The fear phenotype in the Pet-1 KO mice was not associated with
alterations in other anxiety- or stress-related phenotypes. This isnstructions. Genotypes did not differ in average apical (B) or basilar (C) dendritic length,
endritic intersections (n = 10–11 mice per genotype, n = 8 neurons per mouse). Scale
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related assays and forced swim test (Schaefer et al., 2009). However,
other studies have reported increased anxiety-like behavior in Pet-1
KO mice in the elevated plus-maze (Hendricks et al., 2003; Liu et al.,
2010), marble burying, and acoustic startle (Schaefer et al., 2009)
tests. Conversely, others have reported decreased anxiety-like behavior
in Pet-1 KOmice in the elevated plus-maze and novelty-suppressed as-
says (Kiyasova et al., 2011), similar to the anxiolytic-like effects on
marble-burying and the open field test seen in serotonin-depleted
mice fed a tryptophan-deficient diet (Browne et al., 2012). In the pres-
ent study as well as those cited above, mice underwent batteries of
tests related to anxiety, stress, and emotional regulation; thus, it is pos-
sible that the effects of the stressors inherent in these tests differ across
genotypes. Such an interaction could contribute to the discrepancies
seen across studies in which both the specific tests used and the order
in which they were given may vary (Browne et al., 2012; Fernandez
and Gaspar, 2012).
On the other hand, genetic background may underlie variability in
mutant anxiety-related phenotypes across studies (Crusio et al., 2009;
Fernandez and Gaspar, 2012; Holmes and Hariri, 2003). Pet-1 KO mice
have been examined on C57BL/6J × ‘129Sv’ hybrid and C57BL/6J-
backcrossed (as in the current) genetic backgrounds. However,
Hendricks et al., 2003 and Schaefer et al., 2009 both used hybrid
backgrounds, but found different phenotypes. Therefore, the impact of
Pet-1 KO on anxiety-like behavior is likely related to other factors.
Given the importance of the serotonin system in modulating sensitivity
to stress, one such factor could be variation in stress levels related to
prior test history and local testing and housing conditions. This would
echo other findings in mutants with altered serotonin function (e.g.,
TPH1 and Tph2 deletion, (Beaulieu et al., 2008) vs. (Savelieva et al.,
2008)). Thus, in contrast to learned fear, complex environmental inter-
actions and compensatory alterations may mitigate and mask effects
of serotonin perturbation on unconditioned anxiety-like behavior.
This could relate to anxiety's recruitment of widespread and semi-
redundant regions (Singewald et al., 2003), whereas fear learning
is highly dependent on the function of a discrete circuit.Fig. 6. Variation in the human PET-1 gene predicts threat-related amygdala reactivity. Mai
centromedial (B) amygdala ROIs in the entire sample (n = 332). Montreal Neurological Instit
y = −6 and z = −20; p b .001, cluster size = 189; right basolateral ROI: max voxel: x =
voxel: x = −24, y = −10 and z = −14; p b 0.001, cluster size = 38; right centromedial ROI
at rs860573 within FEV (PET-1) had elevated right basolateral and left centromedial threat-relTranslation to human amygdala reactivity and psychopathology
Based on our findings in Pet-1 KO mice, we extended our study to
human neural processes. We found that a common SNP, rs860573, in
the PET-1 gene (FEV) is associatedwith altered threat-related amygdala
function. Carriers of the minor A allele exhibited increased amygdala
reactivity to facial expressions signaling threat compared to homozy-
gotes of the major G allele. While this effect is consistent with the
increased and recovery-prone conditioned fear seen in Pet-1 KO mice,
a future fMRI study exploring potential differences in fear conditioning
and extinction in carriers of the minor A allele would be interesting.
Importantly, the increased amygdala reactivity seen in carriers of the
minor A allele was present against a common genetic background, as
all individuals were of self-identified Asian ancestry. This provides
another parallelwith themodification of Pet-1KOphenotypes by genetic
background, and reinforces the notion that serotonin gene variants
associated with emotionality interact strongly with genetic modifiers
(Holmes andHariri, 2003).While it would be interesting to test whether
our observed effect is present against different genetic backgrounds, the
relative rarity of theminor A allele in non-Asian populations will require
sample sizes that exceed those of current studies.
PET-1 (FEV) genotype effects extended to behavioral and clinical
phenotypes that have previously been associated with threat-related
amygdala reactivity (Hariri, 2009). Carriers of the A allele, who exhibited
increased amygdala reactivity, had significantly higher levels of psycho-
pathology and increased trait anxiety. Future work should extend
analyses into clinical populations to directly examine the potential
influence of the PET-1 (FEV) variant on the prevalence of fear-related
disorders. Regardless, the convergence of effects on neural, behavioral,
and clinical phenotypes suggests that PET-1 rs860573 genotype may
impact the development of human serotonin neurons and forebrain
innervation patterns in a manner consistent with that observed in the
Pet-1 KO. Studies utilizing receptor positron emission tomography to
quantify serotonergic innervation in vivo will be valuable in exploring
this possibility (Fisher and Hariri, 2012). Some important limitations
of this human imaging genetics study warrant attention. First, then effects of task (i.e., Angry & Fearful Faces N Shapes) on bilateral basolateral (A) and
ute template coordinates and statistics for the left basolateral ROI: max voxel: x = −22,
28, y = −6 and z = −20; p b 0.001, cluster size = 219; left centromedial ROI: max
:max voxel: x = 28, y = −12 and z = −12; p b .001, cluster size = 67. A allele carriers
ated amygdala reactivity in the Asian subsample (n = 88).
268 C.L. Wellman et al. / Experimental Neurology 250 (2013) 260–269generalizability is limited to those of Asian ancestry. Second, while
consisting of a relatively large sample for a neuroimaging study, our
sample size is small for a genetic association study and we do not have
access to a replication sample. As a result, we caution against over-
interpretation of the reported findings until replication is established in
larger samples (Duncan and Keller, 2011).Conclusions
Loss of brain serotonin via gene deletion of Pet-1 produced an in-
creased fear memory that was liable to recover following extinction,
as well as dendritic hypertrophy in a key brain region mediating fear
and extinction. While previous studies have demonstrated how varia-
tion in genes regulating other major components of the serotonergic
system alter corticolimbic morphology and associated fear extinction pro-
cessing, they have focused on effects likely to produce hyperserotonergia—
for instance, loss of SERT-mediated reuptake or the serotonin 5-HT1A
autoreceptor, which controls serotonin neuronal firing (reviewed in
Holmes, 2008). The current study demonstrates how these phenotypes
are impacted by lifelong hyposerotonergia. Given this point, together
with the complexity and multifaceted nature of the serotonin system, the
current findings add appreciably to our understanding of the effects of ge-
netic variation in the serotonergic system. This is underscored by our pat-
tern of results, which are qualitatively different from that seen with, for
example, SERT gene variation. For instance, PET1 disruption alters fear
encoding and amygdala morphology, whereas SERT disruption alters ex-
tinction encoding and prefrontal morphology (Wellman et al., 2007). At
the same time, the finding that gene variations producing either
hyperserotonergia or hyposerotonergia both strongly modulate corti-
colimbic systems regulating emotion supports the broader conclusion
that disruptions of the serotonin system in either direction can have re-
markably convergent effects on corticolimbic systems regulating emotion.
Consistent with the effects of PET-1 deletion, in a sample of Asian-
ancestry human subjects, a significant association was found between
a common PET-1 genetic polymorphism and threat-related amygdala
reactivity. The presence of this association, as well as an association
with clinical diagnosis and with trait anxiety, suggests that the
penetrance of this variant may be robust. This is consistent with the
critical role of PET1 in the development of serotonergic neurons, and
predicts that genetic variation in PET1 may manifest an even stronger
influence on risk for mood and anxiety disorders when operating in
interaction with, for example, variants in other serotonergic genes
(e.g., 5-HTTLPR) and environmental triggers (e.g., childhood trauma).
Our data provide novel, convergent evidence of the consequences of
Pet-1 gene deletion and variation on amygdala-mediated fear. These
findings add to a growing literature demonstrating the lasting impact
of genetic variation and ontogenic disruption of the serotonin system
in regulating emotional behavior and influencing risk for mood and
anxiety disorders, and will provide a foundation for future studies
exploring the underlying biology in greater detail and the influence of
PET1 variation in interaction with other risk factors in larger human
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